Search
for
Sort by
Research 30 of 1000+
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Folliculitis decalvans managed with adalimumab: A case report
- Lupus erythematosus: systemic and cutaneous manifestations
- Possible Immunomodulating Effect of Retinol on Cytokines Secretion in Patients with Recurrent Furunculosis
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Ottawa, Ontario, Canada, February 13–16, 2013
- COVID-19 and Sex Differences
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Weight Gain and Hair Loss during Anti-TNF Therapy
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous drug reactions
- Abstracts
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients
- Diagnostic challenges in determining alopecia areata
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Alopecia Areata
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice